News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,906 Results
Type
Article (2562)
Company Profile (45)
Press Release (37298)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14186)
Career Advice (78)
Deals (2102)
Drug Delivery (9)
Drug Development (4142)
Employer Resources (10)
FDA (440)
Job Trends (780)
News (20258)
Policy (1055)
Tag
Academia (144)
Allergies (7)
Alliances (3491)
ALS (5)
Alzheimer's disease (54)
Antibody-drug conjugate (ADC) (24)
Approvals (445)
Artificial intelligence (28)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (6)
Breast cancer (43)
Cancer (318)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (28)
CDC (1)
Cell therapy (78)
Cervical cancer (2)
Clinical research (3423)
Collaboration (188)
Company closure (2)
Compensation (99)
COVID-19 (183)
CRISPR (11)
C-suite (98)
Cystic fibrosis (6)
Data (398)
Denatured (6)
Depression (11)
Diabetes (16)
Diagnostics (481)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (31)
Drug pricing (10)
Duchenne muscular dystrophy (38)
Earnings (4484)
Editorial (4)
Employer branding (1)
Employer resources (8)
Events (6372)
Executive appointments (129)
FDA (575)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (153)
Gene editing (30)
Generative AI (1)
Gene therapy (49)
GLP-1 (63)
Government (157)
Guidances (23)
Healthcare (707)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (32)
Immuno-oncology (11)
Indications (4)
Infectious disease (193)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (24)
Interviews (7)
IPO (1001)
IRA (7)
Job creations (293)
Job search strategy (62)
Kidney cancer (6)
Labor market (11)
Layoffs (49)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (29)
Lymphoma (12)
Machine learning (2)
Management (4)
Manufacturing (48)
MASH (13)
Medical device (312)
Medtech (312)
Mergers & acquisitions (1210)
Metabolic disorders (67)
Multiple sclerosis (20)
Neurodegenerative disease (23)
Neuropsychiatric disorders (8)
Neuroscience (152)
NextGen: Class of 2025 (353)
Non-profit (154)
Now hiring (10)
Obesity (29)
Opinion (17)
Ovarian cancer (17)
Pain (23)
Pancreatic cancer (21)
Parkinson's disease (10)
Partnered (4)
Patents (50)
Patient recruitment (22)
Peanut (1)
People (5844)
Pharmaceutical (5)
Phase I (1468)
Phase II (1696)
Phase III (913)
Pipeline (340)
Policy (15)
Postmarket research (30)
Preclinical (639)
Press Release (2)
Prostate cancer (7)
Psychedelics (2)
Radiopharmaceuticals (14)
Rare diseases (52)
Real estate (425)
Recruiting (5)
Regulatory (904)
Reports (7)
Research institute (147)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
Schizophrenia (16)
Series A (41)
Series B (18)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (1)
The Weekly (3)
Vaccines (48)
Venture capital (14)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (18)
Last 7 days (28)
Last 30 days (153)
Last 365 days (2453)
2026 (27)
2025 (2440)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (17)
Asia (1938)
Australia (305)
California (1526)
Canada (234)
China (76)
Colorado (49)
Connecticut (15)
Delaware (5)
Europe (3996)
Florida (62)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (19)
India (2)
Indiana (54)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (47)
Massachusetts (539)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (127)
New York (77)
North Carolina (128)
Northern California (732)
Ohio (41)
Oklahoma (2)
Oregon (5)
Pennsylvania (102)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (627)
Tennessee (4)
Texas (149)
United States (3052)
Utah (4)
Virginia (11)
Washington D.C. (2)
Washington State (90)
West Virginia (1)
Wisconsin (10)
39,906 Results for "ideaya biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
GSK and Ideaya first linked up in 2020 to advance novel therapies for solid tumors. It is unclear why the pharma terminated the partnership.
December 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
2 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events
November 24, 2025
·
2 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events
October 27, 2025
·
2 min read
Press Releases
IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
November 4, 2025
·
14 min read
Press Releases
IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
December 10, 2025
·
4 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming September 2025 Investor Relations Events
August 25, 2025
·
2 min read
Press Releases
IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma
December 11, 2025
·
5 min read
Press Releases
IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types
December 2, 2025
·
5 min read
Press Releases
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
December 5, 2025
·
3 min read
1 of 3,991
Next
